1. Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study 
Eli O. Meltzer, MD, Paul H. Ratner, MD, MBA, Thomas McGraw, PhD 
The Journal of Allergy and Clinical Immunology: In Practice 
Volume 3, Issue 5, Pages (September 2015)
DOI: /j.jaip
Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Figure 1
Disposition of participants. The ITT population included all participants who were randomized to a study treatment. The safety population included all participants who took at least 1 dose of study medication. The EE population (ie, those analyzed) included all participants in the ITT population who had at least 1 complete full day (morning and evening) of postdose reflective nasal congestion symptom scores.
The Journal of Allergy and Clinical Immunology: In Practice 2015 3, DOI: ( /j.jaip )
Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Figure 2
Reflective nasal congestion scores by treatment and study day (ITT population). Because the y-axis does not begin from 0, the figure may exaggerate the placebo effect of the first dose.
The Journal of Allergy and Clinical Immunology: In Practice 2015 3, DOI: ( /j.jaip )
Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions